James George Chopas

Insider Reports History

Location
Waltham, MA
Signature
/s/ David Watson, attorney-in-fact for James Chopas
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James George Chopas:

Company Role Class Num Shares Value Price $ Report Date Ownership
Apellis Pharmaceuticals, Inc. VP/Chief Accounting Officer Common Stock 51,869 $1,026,637 $19.79 20 Jan 2026 Direct
Apellis Pharmaceuticals, Inc. VP/Chief Accounting Officer Stock Option (Right to Buy) 11,250 $218,137 $19.39 09 Jun 2025 Direct

Insider Reports Filed by James George Chopas

Symbol Company Period Transactions Value $ Form Type Role Filing Time
APLS Apellis Pharmaceuticals, Inc. 20 Jan 2026 1 -$14,370 4 VP/Chief Accounting Officer 21 Jan 2026, 16:18
APLS Apellis Pharmaceuticals, Inc. 13 Jan 2026 1 -$19,369 4 VP/Chief Accounting Officer 15 Jan 2026, 16:34
APLS Apellis Pharmaceuticals, Inc. 15 Sep 2025 1 -$4,572 4 VP/Chief Accounting Officer 17 Sep 2025, 20:08
APLS Apellis Pharmaceuticals, Inc. 02 Sep 2025 1 -$15,386 4 VP/Chief Accounting Officer 03 Sep 2025, 13:06
APLS Apellis Pharmaceuticals, Inc. 18 Jun 2025 1 $0 4 VP/Chief Accounting Officer 20 Jun 2025, 16:09
APLS Apellis Pharmaceuticals, Inc. 09 Jun 2025 1 +$218,138 4 VP/Chief Accounting Officer 11 Jun 2025, 16:15
APLS Apellis Pharmaceuticals, Inc. 17 Mar 2025 1 -$4,543 4 VP/Chief Accounting Officer 18 Mar 2025, 12:27
APLS Apellis Pharmaceuticals, Inc. 22 Jan 2025 1 -$33,346 4 VP/Chief Accounting Officer 23 Jan 2025, 15:19
APLS Apellis Pharmaceuticals, Inc. 17 Jan 2025 2 -$21,420 4 VP/Chief Accounting Officer 21 Jan 2025, 15:56
APLS Apellis Pharmaceuticals, Inc. 13 Jan 2025 1 -$22,474 4 VP/Chief Accounting Officer 14 Jan 2025, 16:09
APLS Apellis Pharmaceuticals, Inc. 16 Sep 2024 1 -$6,952 4 VP/Chief Accounting Officer 17 Sep 2024, 16:08
APLS Apellis Pharmaceuticals, Inc. 03 Sep 2024 1 -$21,720 4 VP/Chief Accounting Officer 04 Sep 2024, 16:07
APLS Apellis Pharmaceuticals, Inc. 15 Mar 2024 1 -$10,389 4 VP/Chief Accounting Officer 18 Mar 2024, 16:19
APLS Apellis Pharmaceuticals, Inc. 22 Jan 2024 1 -$68,961 4 VP/Chief Accounting Officer 23 Jan 2024, 18:00
APLS Apellis Pharmaceuticals, Inc. 16 Jan 2024 3 +$743,579 4 VP/Chief Accounting Officer 17 Jan 2024, 16:45
APLS Apellis Pharmaceuticals, Inc. 23 Oct 2023 1 -$6,077 4 VP/Chief Accounting Officer 24 Oct 2023, 16:20
APLS Apellis Pharmaceuticals, Inc. 14 Sep 2023 1 $0 4 VP/Chief Accounting Officer 18 Sep 2023, 17:20
APLS Apellis Pharmaceuticals, Inc. 31 Aug 2023 1 -$22,716 4 VP/Chief Accounting Officer 01 Sep 2023, 17:08
APLS Apellis Pharmaceuticals, Inc. 21 Feb 2023 3 -$19,539 4 VP/Chief Accounting Officer 22 Feb 2023, 05:44
APLS Apellis Pharmaceuticals, Inc. 20 Jan 2023 1 -$47,834 4 VP/Chief Accounting Officer 24 Jan 2023, 15:58
APLS Apellis Pharmaceuticals, Inc. 12 Jan 2023 2 +$795,903 4 VP/Chief Accounting Officer 17 Jan 2023, 18:26
APLS Apellis Pharmaceuticals, Inc. 20 Oct 2022 1 -$7,540 4 VP/Chief Accounting Officer 24 Oct 2022, 17:09
APLS Apellis Pharmaceuticals, Inc. 30 Aug 2022 1 -$32,833 4 VP/Chief Accounting Officer 31 Aug 2022, 16:26
APLS Apellis Pharmaceuticals, Inc. 21 Jan 2022 2 $0 4/A VP/Chief Accounting Officer 07 Feb 2022, 19:06
APLS Apellis Pharmaceuticals, Inc. 20 Oct 2021 1 $0 4 VP/Chief Accounting Officer 27 Oct 2021, 16:31
APLS Apellis Pharmaceuticals, Inc. 30 Aug 2021 2 $0 4 VP, Corporate Controller / Chief Accounting Officer 01 Sep 2021, 16:34
APLS Apellis Pharmaceuticals, Inc. 30 Aug 2021 0 $0 3 Exhibit 24.1 - Power of Attorney VP, Corporate Controller / Chief Accounting Officer 01 Sep 2021, 16:07